NCT01886599View on ClinicalTrials.gov

Study of the Pharmacokinetics and Safety of Asunaprevir in Patients With Kidney Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Hepatitis C
Interventions
DRUG

Asunaprevir

Trial Locations (3)

32809

Orlando Clinical Research Center, Orlando

37920

New Orleans Center For Clinical Research, Knoxville

55404

Davita Clinical Research, Minneapolis

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01886599 - Study of the Pharmacokinetics and Safety of Asunaprevir in Patients With Kidney Disease | Biotech Hunter | Biotech Hunter